Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lundbeck

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Lundbeck's 2013 CNS (central nervous system) sales performance.

Lundbeck sways NICE with new Brintellix data

Lundbeck sways NICE with new Brintellix data The recommendation comes after Lundbeck submitted further evidence for Brintellix (vortioxetine) that NICE had requested in previous draft guidance. ... In 2013 Lundbeck partnered with Takeda to promote Brintellix with analysts predicting worldwide sales

Axovant takes Alzheimer's drug into phase III

Axovant takes Alzheimer's drug into phase III Lundbeck and Otsuka also have a 5-HT6 antagonist called idalopirdine (Lu AE58054) in phase III trials that are due to report data between November and mid-2016.

CHMP recommends 19 new medicines for European approval

CHMP recommends 19 new medicines for European approval Generic Approvals. Additionally five generic medicines were recommended by the CHMP, including Aripiprazole Accord (aripiprazole) - a version of Lundbeck's schizophrenia and bipolar disorder treatment Abilify.

Allergan and Gedeon finally get antipsychotic green light

Allergan and Gedeon finally get antipsychotic green light Once-monthly examples include Otsuka/Lundbeck's Abilify Maintena (aripiprazole) and Johnson and Johnson's Invega Sustenna (paliperidone palmitate), while J&J is also developing a three-monthly paliperidone depot that ... It will reach the market shortly

Harnessing clinical data

Harnessing clinical data In five years' time, it will be possible to measure a full set of vitals 24 hours a day,” according to Mike Bartlett, senior enterprise architect at Lundbeck, and this will

[ Previous 5 results ] 8 9 10 11 12 13 14 15 16 17 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...
Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and...
Understanding the evolving CAR-T market
In 2017 the approval of the first CAR-T treatment took the world by storm, transforming the way cancer is treated, but two years later more than 500 CAR-Ts are in...

Infographics